BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29655803)

  • 21. Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancer.
    Yoshimura A; Gemma A; Hosoya Y; Komaki E; Hosomi Y; Okano T; Takenaka K; Matuda K; Seike M; Uematsu K; Hibino S; Shibuya M; Yamada T; Hirohashi S; Kudoh S
    Genes Chromosomes Cancer; 2003 Jun; 37(2):159-64. PubMed ID: 12696064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Khandanpour C; Cadeddu RP; Gutekunst J; Wilk CM; Fenk R; Zilkens C; Hermsen D; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Leukemia; 2016 Mar; 30(3):683-91. PubMed ID: 26601782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Role of CXCR4/STAT3 in mesenchymal stromal cell-mediated drug resistance of acute leukemia cells].
    Tang Y; Guo Q; Zhi Y; Jin X; Xia B; Guo S; Tian C; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2016 Feb; 37(2):119-23. PubMed ID: 27014981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galectin 3 as a guardian of the tumor microenvironment.
    Ruvolo PP
    Biochim Biophys Acta; 2016 Mar; 1863(3):427-437. PubMed ID: 26264495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.
    Zeng Z; Shi YX; Tsao T; Qiu Y; Kornblau SM; Baggerly KA; Liu W; Jessen K; Liu Y; Kantarjian H; Rommel C; Fruman DA; Andreeff M; Konopleva M
    Blood; 2012 Sep; 120(13):2679-89. PubMed ID: 22826565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 28. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
    Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
    J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and role of fibroblast activation protein α in acute myeloid leukemia.
    Mei S; Zhang Y; Yu L; Chen G; Zi F
    Oncol Rep; 2021 Feb; 45(2):641-651. PubMed ID: 33416165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular alterations in bone marrow mesenchymal stromal cells derived from acute myeloid leukemia patients.
    von der Heide EK; Neumann M; Vosberg S; James AR; Schroeder MP; Ortiz-Tanchez J; Isaakidis K; Schlee C; Luther M; Jöhrens K; Anagnostopoulos I; Mochmann LH; Nowak D; Hofmann WK; Greif PA; Baldus CD
    Leukemia; 2017 May; 31(5):1069-1078. PubMed ID: 27833093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients.
    Ruvolo PP; Qiu Y; Coombes KR; Zhang N; Neeley ES; Ruvolo VR; Hail N; Borthakur G; Konopleva M; Andreeff M; Kornblau SM
    BBA Clin; 2015 Dec; 4():59-68. PubMed ID: 26674329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment.
    Jin L; Tabe Y; Kojima K; Shikami M; Benito J; Ruvolo V; Wang RY; McQueen T; Ciurea SO; Miida T; Andreeff M; Konopleva M
    J Mol Med (Berl); 2013 Dec; 91(12):1383-97. PubMed ID: 23955073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.
    Lopes MR; Pereira JK; de Melo Campos P; Machado-Neto JA; Traina F; Saad ST; Favaro P
    Sci Rep; 2017 Jan; 7():40707. PubMed ID: 28084439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated SH3BP5 Correlates with Poor Outcome and Contributes to the Growth of Acute Myeloid Leukemia Cells.
    Li M; Hao S; Li C; Xiao H; Sun L; Yu Z; Zhang N; Xiong Y; Zhao D; Yin Y
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31546831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal Adhesion Kinase as a Potential Target in AML and MDS.
    Carter BZ; Mak PY; Wang X; Yang H; Garcia-Manero G; Mak DH; Mu H; Ruvolo VR; Qiu Y; Coombes K; Zhang N; Ragon B; Weaver DT; Pachter JA; Kornblau S; Andreeff M
    Mol Cancer Ther; 2017 Jun; 16(6):1133-1144. PubMed ID: 28270436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia.
    Li L; Man J; Zhao L
    Exp Biol Med (Maywood); 2021 Jan; 246(1):84-96. PubMed ID: 33167688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway.
    Cheng H; Ding J; Tang G; Huang A; Gao L; Yang J; Chen L
    Mol Med; 2021 Oct; 27(1):128. PubMed ID: 34656078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3 expression in pituitary adenomas as a marker of aggressive behavior.
    Righi A; Morandi L; Leonardi E; Farnedi A; Marucci G; Sisto A; Frank G; Faustini-Fustini M; Zoli M; Mazzatenta D; Agati R; Foschini MP
    Hum Pathol; 2013 Nov; 44(11):2400-9. PubMed ID: 24007691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.